These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 32200578

  • 41. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
    Hori Y, Fujimoto E, Nishikawa Y, Nakamura T.
    J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 48. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M, Mion MM, Di Serio F, Caputo M, Ottomano C, Plebani M.
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy.
    MacLean HN, Abbott JA, Ward DL, Huckle WR, Sisson DD, Pyle RL.
    J Vet Intern Med; 2006 Jul; 20(2):284-9. PubMed ID: 16594584
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
    Tesic M, Seferovic J, Trifunovic D, Djordjevic-Dikic A, Giga V, Jovanovic I, Petrovic O, Marinkovic J, Stankovic S, Stepanovic J, Ristic A, Petrovic M, Mujovic N, Vujisic-Tesic B, Beleslin B, Vukcevic V, Stankovic G, Seferovic P.
    J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Circulating natriuretic peptides in cats with heart disease.
    Connolly DJ, Magalhaes RJ, Syme HM, Boswood A, Fuentes VL, Chu L, Metcalf M.
    J Vet Intern Med; 2008 Oct; 22(1):96-105. PubMed ID: 18289295
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy.
    Hernández-Romero D, Jover E, Martínez CM, Andreu-Cayuelas JM, Orenes-Piñero E, Romero-Aniorte AI, Casas T, Cánovas S, Montero-Argudo JA, Valdés M, de la Morena G, Marín F.
    Eur J Clin Invest; 2015 Feb; 45(2):179-86. PubMed ID: 25524713
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.
    Kittleson MD, Côté E.
    J Feline Med Surg; 2021 Nov; 23(11):1028-1051. PubMed ID: 34693811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.